Predictors of recurrence of atrial fibrillation within the first 3 months after ablation.

ABSTRACT:

Aims

Freedom from atrial fibrillation (AF) at 1 year can be achieved in 50-70% of patients undergoing catheter ablation. Recurrent AF early after ablation most commonly terminates spontaneously without further interventional treatment but is associated with later recurrent AF. The aim of this investigation is to identify clinical and procedural factors associated with recurrence of AF early after ablation.

Methods and results

We retrospectively analysed data for recurrence of AF within the first 3 months after catheter ablation from the randomized controlled AXAFA-AFNET 5 trial, which demonstrated that continuous anticoagulation with apixaban is as safe and as effective compared to vitamin K antagonists in 678 patients undergoing first AF ablation. The primary outcome of fir

SUBMITTER: Zink MD 

PROVIDER: S-EPMC7478316 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature